These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9414794)

  • 1. Efficacy of endothelin-1 receptor antagonist for protecting the function of grafted livers from preservation-reperfusion injury in pigs.
    Ohkubo H; Fujioka H; Kamohara Y; Mizoe A; Azuma T; Furui TJ; Kanematsu T
    Transplant Proc; 1997 Dec; 29(8):3467-8. PubMed ID: 9414794
    [No Abstract]   [Full Text] [Related]  

  • 2. Attenuation of ischemic liver injury by a non-selective endothelin receptor antagonist.
    Jin MB; Zhu Y; Zhang S; Ishizaki N; Tanaka H; Subbotin VM; Lee RG; Starzl TE; Todo S
    Transplant Proc; 1997; 29(1-2):1335. PubMed ID: 9123330
    [No Abstract]   [Full Text] [Related]  

  • 3. Beneficial effect of machine perfusion preservation on liver transplantation from non-heart-beating donors.
    Iwamoto H; Matsuno N; Narumi Y; Uchiyama M; Kozaki K; Degawa H; Hama K; Kikuchi K; Takeuchi H; Kozaki M; Nagao T
    Transplant Proc; 2000 Nov; 32(7):1645-6. PubMed ID: 11119873
    [No Abstract]   [Full Text] [Related]  

  • 4. Ischemic damage prevention by N-acetylcysteine treatment of the donor before orthotopic liver transplantation.
    Regueira FM; Hernández JL; Sola I; Cienfuegos JA; Pardo F; Díez-Caballero A; Sierra A; Nwose E; Espí A; Baixaúli J; Rotellar F
    Transplant Proc; 1997 Dec; 29(8):3347-9. PubMed ID: 9414743
    [No Abstract]   [Full Text] [Related]  

  • 5. Peri- and postoperative kinetics of endothelin-1/big endothelin-1 and effects of endothelin antagonist in porcine liver transplantation from non-heart-beating donors.
    Fukunaga K; Takada Y; Gu M; Ishiguro S; Seino K; Taniguchi H; Yuzawa K; Otsuka M; Goto K; Fukao K
    Transplant Proc; 2000 Nov; 32(7):1647-9. PubMed ID: 11119874
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased flow rate of preservation solution in the hepatic artery during organ preservation can improve postischemic liver function.
    Blumhardt G; Lemmens P; Topalidis T; Meissler M; Baer P; Steffen R; Schön M; Müller C; Neuhaus P
    Transplant Proc; 1993 Aug; 25(4):2540-2. PubMed ID: 8356660
    [No Abstract]   [Full Text] [Related]  

  • 7. Endothelin antagonist improves viability of liver grafts from non-heart-beating donors.
    Fukunaga K; Takada Y; Taniguchi H; Otsuka M; Fukao K
    Transplant Proc; 1999; 31(1-2):460-1. PubMed ID: 10083190
    [No Abstract]   [Full Text] [Related]  

  • 8. Endothelin A receptor blockade reduces hepatic ischemia/reperfusion injury after warm ischemia in a pig model.
    Uhlmann D; Armann B; Gaebel G; Ludwig S; Hess J; Pietsch UC; Escher E; Fiedler M; Tannapfel A; Hauss J; Witzigmann H
    J Gastrointest Surg; 2003; 7(3):331-9. PubMed ID: 12654557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycine in Carolina rinse solution reduces reperfusion injury, improves graft function, and increases graft survival after rat liver transplantation.
    Bachmann S; Peng XX; Currin RT; Thurman RG; Lemasters JJ
    Transplant Proc; 1995 Feb; 27(1):741-2. PubMed ID: 7879166
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of preservation/reperfusion liver injury by the protease inhibitor aprotinin after cold ischemic storage.
    Oldhafer KJ; Schüttler W; Wiehe B; Hauss J; Pichlmayr R
    Transplant Proc; 1991 Oct; 23(5):2380-1. PubMed ID: 1718071
    [No Abstract]   [Full Text] [Related]  

  • 11. Alleviation of 3.5-hour warm ischemic injury of the liver in pigs by cyclosporine pretherapy.
    Kim YI; Kawano K; Nakashima K; Goto S; Kobayshi M
    Transplantation; 1991 Mar; 51(3):731-3. PubMed ID: 2006534
    [No Abstract]   [Full Text] [Related]  

  • 12. Graft viability assay for preserved livers using hepatic protein synthesis rates in a rat liver transplantation model.
    Matsui Y; Asano T; Enomoto K; Uematsu T; Nakagohri T; Tokoro Y; Jingu K; Miyauchi H; Maruyama M; Iwashita C
    Transplant Proc; 1994 Aug; 26(4):2388-9. PubMed ID: 8066782
    [No Abstract]   [Full Text] [Related]  

  • 13. Rewarming injury of the graft liver in orthotopic liver transplantation.
    Hayashi M; Shimizu Y; Murakami M; Kusano M
    Transplant Proc; 1998 Nov; 30(7):3692-3. PubMed ID: 9838620
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of preservation and reperfusion injury in human liver transplantation.
    Mueller AR; Platz KP; Schumacher G; Riger J; Gebauer B; Neumann U; Neuhaus P
    Transplant Proc; 1997 Dec; 29(8):3455-7. PubMed ID: 9414788
    [No Abstract]   [Full Text] [Related]  

  • 15. Bosentan, an endothelin antagonist, augments hepatic graft function by reducing graft circulatory impairment following ischemia/reperfusion injury.
    Ricciardi R; Schaffer BK; Shah SA; Quarfordt SH; Banner BF; Wheeler SM; Donohue SE; Meyers WC; Chari RS
    J Gastrointest Surg; 2001; 5(3):322-9. PubMed ID: 11360057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of SOD, catalase, and epoprostenol on 24-hour liver preservation in pigs.
    Lemmens HP; Schön MR; Blumhardt G; Filler D; Brandau O; Meissler M; Baer P; von Baehr R; Neuhaus P
    Transplant Proc; 1993 Aug; 25(4):2549-53. PubMed ID: 8356665
    [No Abstract]   [Full Text] [Related]  

  • 17. Change in serum levels of endothelin-1 in porcine liver transplantation and efficacy of ET-1 antagonist to protect damage to liver grafts.
    Fujioka H; Mizoe A; Watanabe Y; Gu W; Kamohara Y; Yamaguchi J; Azuma T; Furui J; Kanematsu T
    Transplant Proc; 1997; 29(1-2):869-70. PubMed ID: 9123561
    [No Abstract]   [Full Text] [Related]  

  • 18. Beneficial effect of the platelet-activating factor antagonist WEB 2170 on reperfusion injury after orthotopic liver transplantation.
    Spiegel HU; Oldhafer KJ; Lang H; Schüttler W; Bremer C; Pichlmayr R
    Transplant Proc; 1995 Oct; 27(5):2884-5. PubMed ID: 7482955
    [No Abstract]   [Full Text] [Related]  

  • 19. Pilot study: Carolina Rinse Solution improves graft function after orthotopic liver transplantation in humans.
    Bachmann S; Bechstein WO; Keck H; Lemmens HP; Brandes N; John AK; Lemasters JJ; Neuhaus P
    Transplant Proc; 1997; 29(1-2):390-2. PubMed ID: 9123051
    [No Abstract]   [Full Text] [Related]  

  • 20. Protecting the viability of hepatic allografts procured from non-heart-beating donors by blockade of endothelin and platelet activating factor in porcine liver transplantation.
    Fukunaga K; Takada Y; Taniguchi H; Yuzawa K; Otsuka M; Todoroki T; Goto K; Fukao K
    Int Surg; 1998; 83(3):226-31. PubMed ID: 9870780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.